125I-galanin binding sites in Alzheimer's disease: Increases in hippocampal subfields and a decrease in the caudate nucleus

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1106-1113

  Rodríguez Puertas, Rafael ^a,b   Nilsson, Siv ^a   Pascual, Julio ^c   Pazos, Angel ^b   Hökfelt, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

125I Human galanin; Alzheimer's disease; Cholinergic system; Human brain; Neuropeptides

Indexed keywords

GALANIN; IODINE 125; RADIOACTIVE IODINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN CORTEX; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SENILE DEMENTIA; SUBSTANTIA NIGRA; METABOLISM; MIDDLE AGED; TISSUE DISTRIBUTION;

AGED; ALZHEIMER DISEASE; AUTORADIOGRAPHY; BINDING SITES; CAUDATE NUCLEUS; FEMALE; GALANIN; HIPPOCAMPUS; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; TISSUE DISTRIBUTION;

EID: 0030614903     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031106.x     Document Type: Article

References (50)

1. Arai H., Takahashi T., Kimura M., Noguchi I., Minami M., and Iizuka R. (1991) Post mortem human brain tissue investigations of neurotransmitters in aging and in AD/SDAT, in Biological Psychiatry, Vol. 2 (Racagni G., Brunello N., and Fukada T., eds), pp. 131-133. Excerpta Medica, Amsterdam.
2. Beal M. F., Clevens R. A., Chattha G. K., MacGarvey U. M., Mazurek M. F., and Gabriel S. M. (1988a) Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex. J. Neurochem. 51, 1935-1941.
3. Beal M. F., Gabriel S. M., Swartz K. J., and MacGarvey U. M. (1988b) Distribution of galanin-like immunoreactivity in baboon brain. Peptides 9, 847-851.
4. Beal M. F., MacGarvey U., and Swartz K. J. (1990) Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Ann. Neurol. 28, 157-161.
5. Benzing W. C., Kordower J. H., and Mufson E. J. (1993) Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes. J. Comp. Neurol. 336, 31-39.
6. Berretini W. H., Kaye W. H., Sunderland T., May C., Gwirtsman H. E., Mellow A., and Alright A. (1988) Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease. Neuropsychobiology 19, 64-68.
7. Bonnefond C., Palacios J. M., Probst A., and Mengod G. (1990) Distribution of galanin mRNA containing cells and galanin receptor binding sites in human and rat hypothalamus. Eur. J. Neurosci. 2, 629-637.
8. Chan-Palay V. (1988a) Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist. Brain Res. Bull. 21, 465.
9. Chan-Palay V. (1988b) Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 273, 543.
10. Chan-Palay V., Ernfors P., and Persson H. (1990) Galanin gene expression in the nucleus basalis of Meynert in senile dementia of the Alzheimer type. Dementia 1, 192-196.
11. Cortés R., Probst A., and Palacios J. M. (1987) Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: forebrain. Neuroscience 20, 65-107.
12. Cortés R., Villar M. J., Verhofstad A., and Hökfelt T. (1990) Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc. Natl. Acad. Sci. USA 87, 7742-7746.
13. Crawley J. N. (1995) Biological actions of galanin. Regul. Pept. 59, 1-16.
14. Cross R. B. (1983) Demonstration of neurofibrillary tangles in paraffin sections: a quick and simple method using a modification of Palmgren's method. Med. Lab. Sci. 39, 67-69.
15. 125I] galantide. J. Pharmacol. Exp. Ther. 275, 720-727.
16. Edvinsson L., Minthon L., Ekman R., and Gustafson L. (1993) Neuropeptides in cerbrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration. Dementia 4, 167-171.
17. Evans H. and Shine J. (1991) Human galanin: molecular cloning reveals a unique structure. Endocrinology 129, 1682.
18. Evans H. F., Huntley G. W., Morrison J. H., and Shine J. (1993) Localization of mRNA encoding the protein precursor of galanin in the monkey hypothalamus and basal forebrain. J. Comp. Neurol. 328, 203-212.
19. Fisone G., Bartfai T., Nilsson S., and Hökfelt T. (1991) Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Res. 568, 279-284.
20. Fowler C. J., O'Neill C., Winblad B., and Cowburn R. F. (1992) Neurotransmitter, receptor and signal transduction disturbances in Alzheimer's disease. Acta Neurol. Scand. Suppl. 139, 59-62.
21. Gabriel S. M., Bierer L. M., Davidson M., Purohit D. P., Perl D. P., and Harotunian V. (1994) Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease. J. Neurochem. 62, 1516-1523.
22. Gentleman S. M., Falkai P., Bogerts B., Herrero M. T., Polak J. M., and Roberts G. W. (1989) Distribution of galanin-like immunoreactivity in the human brain. Brain Res. 505, 311-315.
23. Geula C. and Mesulam M. M. (1994) Cholinergic systems and related neuropathological predilection patterns in Alzheimer's disease, in Alzheimer's Disease (Terry R. D., Katzman R., and Blick K. L., eds), pp. 263-291. Raven Press, New York.
24. Gottfries C-G., Frederiksen S. O., and Heilig M. (1995) Neuropeptides and Alzheimer's disease. Eur. Neuropsychopharmacol. 5, 491-500.
25. Greenamyre J. T. and Maragos W. F. (1993) Neurotransmitter receptors in Alzheimer's disease. Cerebrovasc. Brain Metab. Rev. 5, 61-94.
26. Habert-Ortoli E., Amiranoff B., Loquet I., Laburthe M., and Mayaux J. F. (1994) Molecular cloning of a functional human galanin receptor. Proc. Natl. Acad. Sci. USA 91, 9780-9783.
27. Hökfelt T., Millhorn D., Seroogy K., Tsuruo Y., Ceccatelli S., Lindh G., Meister B., Melander T., Schalling M., Bartfai T., and Terenius L. (1987) Coexistence of peptides with classical neurotransmitters. Experientia 43, 768-780.
28. 125I-galanin binding sites despite loss of cholinergic neurones to the hippocampus in Alzheimer's disease. Brain Res. 568, 303-306.
29. Ikeda M., Dewar D., and McCulloch J. (1995) Galanin receptor binding sites in the temporal and occipital cortex are minimally affected in Alzheimer's disease. Neurosci. Lett. 192, 37-40.
30. Khachaturian Z. S. (1985) Diagnosis of Alzheimer's disease. Neurosci. Lett. 192, 37-40.
31. 125I-galanin binding sites using the method of in vitro receptor autoradiography. Neurosci. Lett. 120, 179-182.
32. Köhler C. and Chan-Palay V. (1990b) Preservation of galanin receptors in the human basal nucleus of Meynert in senile dementia of the Alzheimer type. Dementia 1, 82-89.
33. Köhler C., Hallman H., Melander T., Hökfelt T., and Norheim E. (1989a) Autoradiographic mapping of galanin receptors in the monkey. J. Chem. Neuroanat. 2, 269-284.
34. Köhler C., Persson A., Melander T., Theodorsson E., Sedvall G., and Hökfelt T. (1989b) Distribution of galanin-binding sites in the monkey and human telencephalon: preliminary observations. Exp. Brain Res. 75, 375-380.
35. Kordower J. H. and Mufson E. J. (1990) Galanin-like immunoreactivity within the primate basal forebrain: differential staining patterns between humans and monkeys. J. Comp. Neurol. 294, 281-292.
36. Kordower J. H., Le H. K., and Mufson E. J. (1992) Galanin immunoreactivity in the primate central nervous system. J. Comp. Neurol 319, 479-500.
37. Kowall N. W. and Beal M. F. (1989) Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease. Neurosci. Lett. 98, 118-123.
38. Lorinet A.-M., Javoy-Agid F., Laburthe M., and Amiranoff B. (1994) Galanin receptors in human hypothalamus: biochemical and structural analysis. Eur. J. Pharmacol. 269, 59-64.
39. McKahn G., Drachmann D., Folstein M., Katzman R., Price D., and Stadlan E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 39, 939-944.
40. Melander T. and Staines W. A. (1986) A galanin-like peptide coexists in putative cholinergic somata of the septum-basal forebrain complex and in acetylcholinesterase containing fibers and varicosities within the hippocampus in the owl monkey (Auotus trivirgatus). Neurosci. Lett. 68, 17-22.
41. Melander T., Staines W. A., Hökfelt T., Rökaeus Å., Eckenstein F., Salvaterra P. M., and Wainer B. H. (1985) Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat. Brain Res. 360, 130-138.
42. Minami M., Makino Y., Arai H., and Iizuka R. (1991) A disorganized increase of galanin-like immunoreactivity in cerebral cortex of Alzheimer-type dementia brains. J. Neural Transm. 4, 285-292.
43. Mufson E. J., Cochran E., Benzing W., and Kordower J. H. (1993) Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 4, 237-250.
44. Rodríguez-Puertas R., Pascual J., and Pazos A. (1996) Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study. Brain Res. 728, 65-71.
45. Tatemoto K., Rökaeus Å., Jörnvall H., McDonald T. J., and Mutt V (1983) Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164, 124-128.
46. Walker L. C., Koliatsos V. E., Kitt C. A., Richardson R. T., Rökaeus Å., and Price D. L. (1989) Peptidergic neurons in the basal forebrain magnocellular complex of the rhesus monkey. J. Comp. Neurol. 280, 272-282.
47. Walker L. C., Rance N. E., Price D. L., and Young W. D. (1991) Galanin mRNA in the nucleus basalis of Meynert complex of baboons and humans. J. Comp. Neurol. 303, 113-120.
48. Walli R., Schäfer H., Morys-Wortmann C., Paetzold G., Nustede R., and Schmidt W. E. (1994) Identification and biochemical characterization of the human brain galanin receptor. J. Mol. Endocrinol. 13, 347-356.
49. Wallin A., Carlsson A., Ekman R., Gottfries C. G., Karlsson I., Svennerholm L., and Widerlöv E. (1991) Hypothalamic monoamines and neuropeptides in dementia. Eur. J. Neuropsychopharmacol. 1, 165-168.
50. Widerlöv E., Wallin A., Gottfries C. G., and Ekman R. (1991) Hypothalamic neuropeptides in neuropsychiatrie illness, in Stress and Related Disorders. From Adaption to Dysfunction (Genazzini A. R., Nappi G., Petraglia F., and Martignoni E., eds), pp. 167-178. Parthenon, Carnforth, Lancashire.